Search - tctmd.com

Displaying 81 - 100 of 390

Sort: Relevancy | Date

Presentation TCT 2018

TCT-6: The CENTER-Collaboration: Outcomes in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation With Balloon-Expandable Valves versus Self-Expandable Valves.

Presenter: Steven R. Bailey, Patrick W. Serruys, Ronak Delewi

September 22, 2018

Presentation TCT 2018

TCT-5: Long-term Preclinical in Vivo Results With a Restorative Aortic Valve

Presenter: Steven R. Bailey, Patrick W. Serruys, Christian M. Spaulding

September 22, 2018

Presentation TCT 2018

TCT-4: Reduction of Stroke With Use of the Double-Filter Cerebral Embolic Protection Device in Patients Undergoing Transfemoral Aortic Valve Replacement With Self-Expandable, Mechanically Implantable And Balloon-Expandable Aortic Valves

Presenter: Steven R. Bailey, Patrick W. Serruys, Julia Seeger

September 22, 2018

Presentation TCT 2018

TCT-3: The Lutonix® Global Drug Coated Balloon Registry Real World Patients With Below the Knee Disease Interim 12 Month Outcomes

Presenter: Steven R. Bailey, Patrick W. Serruys, Steve Henao

September 22, 2018

Presentation TCT 2018

TCT-2: DeepIVUS: A Machine Learning Framework for Fully Automatic IVUS Segmentation

Presenter: Steven R. Bailey, Patrick W. Serruys, David Molony

September 22, 2018

Presentation TCT 2018

TCT-1: Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial

Presenter: Steven R. Bailey, Patrick W. Serruys, Sorin J. Brener

September 22, 2018

News Conference News TCT 2018

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Michael O'Riordan

September 21, 2018

Presentation TCT 2018

TCT-112: Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Event in the Global Leaders Trial

Presenter: George D. Dangas, Germano Di Sciascio, Patrick W. Serruys

September 21, 2018

Presentation TCT 2018

TCT-106: Are Outcomes Following CABG for Left Main Disease Improving Over the Last Decade? A Propensity-Matched Analysis From the EXCEL and SYNTAX Randomized Trials

Presenter: John D. Puskas, Alfredo Trento, Patrick W. Serruys

September 21, 2018

Presentation TCT 2018

TCT-62: Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

Presenter: Antonio L. Bartorelli, David G. Rizik, Patrick W. Serruys

September 21, 2018

Presentation TCT 2018

Does Aspirin Have a Role in the Management of Patients Undergoing PCI?

Presenter: Jeroen J. Bax, Stephan Windecker, Patrick W. Serruys

September 21, 2018

News Conference News ESC 2018

Largest-Ever SCAD Analysis Links Peripartum Status to Poor Outcomes

Todd Neale

August 30, 2018

News Conference News ESC 2018

GLOBAL LEADERS: Ticagrelor Monotherapy Fails to Beat Conventional DAPT After PCI

Michael O'Riordan

August 27, 2018

News Conference News ESC 2018

FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice

Todd Neale

August 26, 2018

News Conference News ESC 2018

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Michael O'Riordan

August 25, 2018

News Conference News EuroPCR 2018

‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease

Yael L. Maxwell

May 22, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

Presentation CIT 2018

Best Practice for PCI: Lessons from SYNTAX II

Presenter: Patrick W. Serruys

March 23, 2018

News Industry News

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

December 06, 2017

Presentation TCT 2017

Implications of Absolute Vessel Size and Scaffold-Vessel Size Mismatch

Presenter: Manel Sabate, Ashok Seth, Patrick W. Serruys

November 01, 2017

Advertisement

TCT-6: The CENTER-Collaboration: Outcomes in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation With Balloon-Expandable Valves versus Self-Expandable Valves.

TCT-5: Long-term Preclinical in Vivo Results With a Restorative Aortic Valve

TCT-4: Reduction of Stroke With Use of the Double-Filter Cerebral Embolic Protection Device in Patients Undergoing Transfemoral Aortic Valve Replacement With Self-Expandable, Mechanically Implantable And Balloon-Expandable Aortic Valves

TCT-3: The Lutonix® Global Drug Coated Balloon Registry Real World Patients With Below the Knee Disease Interim 12 Month Outcomes

TCT-2: DeepIVUS: A Machine Learning Framework for Fully Automatic IVUS Segmentation

TCT-1: Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

TCT-112: Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Event in the Global Leaders Trial

TCT-106: Are Outcomes Following CABG for Left Main Disease Improving Over the Last Decade? A Propensity-Matched Analysis From the EXCEL and SYNTAX Randomized Trials

TCT-62: Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

Does Aspirin Have a Role in the Management of Patients Undergoing PCI?

Largest-Ever SCAD Analysis Links Peripartum Status to Poor Outcomes

GLOBAL LEADERS: Ticagrelor Monotherapy Fails to Beat Conventional DAPT After PCI

FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Best Practice for PCI: Lessons from SYNTAX II

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

Implications of Absolute Vessel Size and Scaffold-Vessel Size Mismatch

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content